SOURCE: Kantar Health

Kantar Health

February 03, 2011 11:39 ET

Kantar Health Names Susan Suponcic Head of Global Market Access

NEW YORK, NY--(Marketwire - February 3, 2011) -  Kantar Health, a leading healthcare-focused global consultancy and marketing insights company, has appointed Susan J. Suponcic, Ph.D., as Senior Vice President of Global Market Access. In this role, she will lead a global practice team who will assist pharmaceutical industry clients in incorporating, substantiating and implementing market access initiatives to capture the value of their innovations and ensure patient access globally.

Dr. Suponcic has more than 13 years of market access experience in both industry and consulting. She joins Kantar Health from Johnson & Johnson, where she held strategic roles in both pricing and health economics, led teams that carried out successful global launch implementations and helped shape the external environment to focus on the value of pharmaceutical innovation. At IMS Health, she led a thriving pharmaceutical pricing consulting practice. 

"Susan's global experience and industry collaboration across R&D, marketing and operating company implementation are key assets as we deliver value to clients navigating the increasingly complex and interrelated global market access environment," says Mike Kelly, President of Kantar Health's Health Sciences Practice.

Dr. Suponcic has a Ph.D. in Managerial Science and Applied Economics from The Wharton School and an M.Sc. in Public Policy and Administration from the London School of Economics and Political Science.

About Kantar Health (www.kantarhealth.com)
As experts in pharmaceutical and biotechnology consulting and market research, Kantar Health offers unique insights and products that deliver proven results for marketing insights, brand marketing, business development and health economics and outcomes professionals, including:

  • The greatest breadth and depth of epidemiology information in the world, spanning patient-reported outcomes and patient care by country, therapy area, specialist -- or whatever combination of data you require
  • Unmatched experience in the complex oncology market that encompasses business development, clinical management, emerging technologies, marketing and sales, payers and providers, reimbursement and strategic and product planning
  • A unique global source of KOLs for multiple therapy areas

Kantar Health's team combines doctorate-level scientific expertise with strong business know-how, ensuring that solutions are both evidence-based and commercially focused. By uniting industry leaders MattsonJack, TNS Healthcare, Consumer Health Sciences and Ziment, we offer a wide range of expertise in emerging as well as established markets, spanning the product life cycle from product portfolio management to licensing, market access to brand and reputation management, detailing to clinical research, patient outcomes and sales force effectiveness to health and safety. And as part of WPP, the largest marketing agency in the world, Kantar Health can leverage the power of the global group with shared offline and online research methodologies but remain culturally specific and nimble. Kantar Health focuses on getting you the best return.

Contact Information

  • Contact Information
    For more information on Kantar Health, please contact
    Paula Paradise
    Vice President of Global Marketing
    Email Contact
    +1-484-442-1431